Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Diabetic Feet

ng-nitroarginine methyl ester has been researched along with Diabetic Feet in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barinova, ME; Sulaieva, OM1
Fujii, T; Kuwano, H; Onimaru, M; Sueishi, K; Yonemitsu, Y1

Other Studies

2 other study(ies) available for ng-nitroarginine methyl ester and Diabetic Feet

ArticleYear
[State of intracellular signaling systems in endothelial dysfunction].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2007, Volume: 53, Issue:6

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Arginine; Clonidine; Diabetic Foot; Endothelium, Vascular; Female; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Platelet Aggregation; Receptors, Adrenergic; Signal Transduction

2007
Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6

    Topics: Animals; Becaplermin; Blood Glucose; Cells, Cultured; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Foot; Enzyme Inhibitors; Genetic Therapy; Glycation End Products, Advanced; Hindlimb; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet-Derived Growth Factor; Pravastatin; Proto-Oncogene Proteins c-sis; Quinolines; Regional Blood Flow; Signal Transduction; Time Factors; Up-Regulation

2008